In December 2024 , the FDA issued warning letters to Prime Peptides, Xcel Peptides, SwissChems, and Summit Research for selling semaglutide, tirzepatide, and retatrutide as unapproved drugs, part of a major escalating enforcement campaign against grey-market peptide vendors that has resulted in warehouse raids, criminal prosecutions, and multiple vendor shutdowns across 2025 and into 2026
Diet can support your body's natural GLP-1 response, but it isn't a substitute for medical treatment where one is needed
Low Plasma Marine N-3 Polyunsaturated Fatty Acids are Associated With Increased Risk of Cardiovascular Events in Patients Treated With Maintenance Hemodialysis
The wave of upcoming medications could also help people who havent responded well to existing GLP-1 drugs
Because orforglipron is non-peptide, its easier to produce and manufacture, which can hopefully keep costs down so we can treat more people with obesity, Rasouli said